NEXT Biometrics Group ASA
NXTBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $3 | $5 | $6 |
| % Growth | 89.9% | -30.2% | -15.9% | – |
| Cost of Goods Sold | $3 | $7 | $8 | $10 |
| Gross Profit | $0 | -$4 | -$3 | -$4 |
| % Margin | 1.4% | -114.7% | -59.6% | -77.9% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | -$1 |
| Operating Expenses | $4 | $3 | $2 | $4 |
| Operating Income | -$4 | -$7 | -$5 | -$8 |
| % Margin | -64.4% | -200.8% | -107.7% | -140% |
| Other Income/Exp. Net | $0 | $0 | $0 | $1 |
| Pre-Tax Income | -$4 | -$6 | -$5 | -$7 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$4 | -$6 | -$5 | -$7 |
| % Margin | -63.2% | -195% | -99.6% | -120.5% |
| EPS | -0.037 | -0.068 | -0.052 | -0.076 |
| % Growth | 45.3% | -31.7% | 32.4% | – |
| EPS Diluted | -0.037 | -0.068 | -0.052 | -0.076 |
| Weighted Avg Shares Out | 107 | 95 | 92 | 89 |
| Weighted Avg Shares Out Dil | 107 | 95 | 92 | 89 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$3 | -$6 | -$4 | -$6 |
| % Margin | -55.2% | -173.1% | -87.9% | -100.5% |